Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | HP518 |
Synonyms | |
Therapy Description |
Limited information is currently available on HP518, a putative proteolysis-targeted chimera (PROTAC) targeting the androgen receptor (AR) (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HP518 | HP 518|HP-518 | Limited information is currently available on HP518, a putative proteolysis-targeted chimera (PROTAC) targeting the androgen receptor (AR) (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05252364 | Phase I | HP518 | A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer | Completed | AUS | 0 |